Skip to content

Randomized controlled study after ATN DBS for treatment of incurable epilepsy, to compare whether there is a difference in the effect of reducing epilepsy seizure among continuous or periodic methods of electric stimulation

A randomized controlled study of ATN DBS epilepsy treatment to assess the therapeutic superiority between cyclic and continuous mode in Korean epilepsy patients(ATTACK study)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0003899
Enrollment
40
Registered
2019-05-09
Start date
2018-04-30
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : To analyze the superiority of ATN DBS (continuous vs. periodic), the DBS treatment is administered in three different crossovers (open time) for three months each.

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A _ Patients aged 19 years and under 65 B _ Patients who have previously been diagnosed with drug-resistant epilepsy C _ Patients with more than two seizures a month, despite two or more anti-interesting medications. D _ Video brainwaves for regionalization of epilepsy and preoperational examinations (MRI, FDG PET, etc.) offer conflicting results without providing an accurate focus E _ Patients who are not adapted to surgical treatment due to anticipated neurological side effects or multiple epilepsy focal lesions

Exclusion criteria

Exclusion criteria: A _ Patient is unable to cooperate due to a confusion in the conscious state (below stupor) B _ Pseudoseizure is performed

Design outcomes

Primary

MeasureTime frame
Number of seizure

Secondary

MeasureTime frame
Change in cognitive function

Countries

Korea, Republic of

Contacts

Public ContactJungil Lee

Samsung Medical Center

jilee@skku.edu+82-2-3410-3494

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026